ACUTE MEGAKARYOCYTIC LEUKAEMIA

This adverse event was reported 55 times

These drugs are most commonly taken by patients reporting ACUTE MEGAKARYOCYTIC LEUKAEMIA:

# Drug Count
0 CARBOPLATIN 14
1 CYCLOPHOSPHAMIDE 11
2 CYCLOPHOSPHAMIDE FOR INJECTION 11
3 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 11
4 PACLITAXEL 10
5 PACLITAXEL (AIBUMIN-BOUND) 10
6 PANTOPRAZOLE 9
7 OLAPARIB 8
8 CYTARABINE 6
9 AZACITIDINE 5
See all common drugs associated with ACUTE MEGAKARYOCYTIC LEUKAEMIA

ACUTE MEGAKARYOCYTIC LEUKAEMIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PSYLLIUM HUSK 1 0.0007
1 RYDAPT 1 0.0005
2 CLOFARABINE 1 0.0004
3 OLAPARIB 8 0.0004
4 MITOXANTRONE HYDROCHLORIDE 2 0.0003
5 AZACITIDINE 5 0.0002
6 HYDROXYUREA 3 0.0001
7 PYRIDOSTIGMINE BROMIDE 1 0.0001
8 ATOVAQUONE 1 0.0001
9 CARBOPLATIN 14 0.0001
See all drugs enriched for association with ACUTE MEGAKARYOCYTIC LEUKAEMIA

ACUTE MEGAKARYOCYTIC LEUKAEMIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 8 0.0004
1 Antimalarial [EPC] 1 0.0001
2 Antiprotozoal [EPC] 1 0.0001
3 Microtubule Inhibitor [EPC] 10 0.0001
4 Alkylating Drug [EPC] 14 0.0001
5 Platinum-based Drug [EPC] 15 0.0001
6 Topoisomerase Inhibitor [EPC] 4 0.0001
7 Nucleoside Metabolic Inhibitor [EPC] 11 0.0000
8 Iron Chelator [EPC] 1 0.0000
9 Protease Inhibitor [EPC] 1 0.0000
See all drug classes enriched for association with ACUTE MEGAKARYOCYTIC LEUKAEMIA